Insmed Insider Trades
NASDAQ: INSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 62 · $83.67M
- Shares bought / sold
- 0 / 635.09K
- Net activity
- Net selling $83.7 million
Insmed insider activity
Over the last 12 months, Insmed insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 62 sales. Insiders bought $0 and sold $83.7 million worth of stock, for net insider selling of $83.7 million. The largest seller was Adsett Roger, with $47.4 million in reported sales.
The most recent filing shows Brennan David R (Director) selling 25,000 shares at $124.00 on Sep 9, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put INSM's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
INSM insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 9, 2026 | Brennan David RDirector | Sale | 25,000 | $3.10M | Form 4 |
| Aug 17, 2026 | SHAROKY MELVIN MDDirector | Sale | 5,000 | $637.65K | Form 4 |
| Aug 10, 2026 | Adsett RogerChief Operating Officer | Sale | 239,850 | $31.96M | Form 4 |
| Aug 10, 2026 | Adsett RogerChief Operating Officer | Option exercise | 80,970 | $2.47M | Form 4 |
| Aug 10, 2026 | Adsett RogerChief Operating Officer | Option exercise | 76,600 | $1.31M | Form 4 |
| Aug 10, 2026 | Adsett RogerChief Operating Officer | Option exercise | 82,280 | $1.12M | Form 4 |
| Aug 6, 2026 | Flammer Martina M.D.Chief Medical Officer | Sale | 18,278 | $2.37M | Form 4 |
| Aug 6, 2026 | Flammer Martina M.D.Chief Medical Officer | Sale | 8,895 | $1.13M | Form 4 |
| Aug 6, 2026 | Flammer Martina M.D.Chief Medical Officer | Option exercise | 8,895 | $229.76K | Form 4 |
| Aug 6, 2026 | Flammer Martina M.D.Chief Medical Officer | Option exercise | 18,278 | $346.37K | Form 4 |
| Jul 23, 2026 | Lewis WilliamChair and CEO | Sale | 5,872 | $624.96K | Form 4 |
| Jul 23, 2026 | Lewis WilliamChair and CEO | Sale | 4,828 | $509.93K | Form 4 |
| Jul 23, 2026 | Lewis WilliamChair and CEO | Option exercise | 4,440 | $76.19K | Form 4 |
| Jul 23, 2026 | Lewis WilliamChair and CEO | Option exercise | 6,260 | $190.68K | Form 4 |
| Jul 9, 2026 | Lewis WilliamChair and CEO | Sale | 3,359 | $398.11K | Form 4 |
| Jul 9, 2026 | Lewis WilliamChair and CEO | Sale | 2,335 | $274.64K | Form 4 |
| Jul 9, 2026 | Lewis WilliamChair and CEO | Sale | 5,005 | $583.33K | Form 4 |
| Jul 9, 2026 | Lewis WilliamChair and CEO | Option exercise | 4,440 | $76.19K | Form 4 |
| Jul 9, 2026 | Lewis WilliamChair and CEO | Option exercise | 6,259 | $190.65K | Form 4 |
| Jul 6, 2026 | Flammer Martina M.D.Chief Medical Officer | Sale | 7,448 | $823.75K | Form 4 |
| Jul 6, 2026 | Flammer Martina M.D.Chief Medical Officer | Sale | 4,854 | $529.18K | Form 4 |
| Jul 6, 2026 | Flammer Martina M.D.Chief Medical Officer | Option exercise | 4,357 | $86.01K | Form 4 |
| Jul 6, 2026 | Flammer Martina M.D.Chief Medical Officer | Option exercise | 7,945 | $231.44K | Form 4 |
| Jun 25, 2026 | Lewis WilliamChair and CEO | Sale | 1,292 | $137.30K | Form 4 |
| Jun 25, 2026 | Lewis WilliamChair and CEO | Sale | 2,456 | $258.54K | Form 4 |
| Jun 25, 2026 | Lewis WilliamChair and CEO | Sale | 3,723 | $388.23K | Form 4 |
| Jun 25, 2026 | Lewis WilliamChair and CEO | Sale | 1,836 | $189.29K | Form 4 |
| Jun 25, 2026 | Lewis WilliamChair and CEO | Sale | 12,091 | $1.24M | Form 4 |
| Jun 25, 2026 | Lewis WilliamChair and CEO | Option exercise | 8,880 | $152.38K | Form 4 |
| Jun 25, 2026 | Lewis WilliamChair and CEO | Option exercise | 12,518 | $381.30K | Form 4 |
| Jun 23, 2026 | Butera SamueleSVP, GM, Global Respiratory | Award | 7,342 | — | Form 4 |
| Jun 22, 2026 | Smith Michael AlexanderChief Legal Officer | Sale | 1,806 | $173.05K | Form 4 |
| Jun 8, 2026 | Lewis WilliamChair and CEO | Sale | 6,515 | $612.61K | Form 4 |
| Jun 5, 2026 | Flammer Martina M.D.Chief Medical Officer | Sale | 1,858 | $192.82K | Form 4 |
| Jun 3, 2026 | Flammer Martina M.D.Chief Medical Officer | Sale | 2,566 | $262.42K | Form 4 |
| Jun 3, 2026 | Lewis WilliamChair and CEO | Sale | 7,605 | $777.76K | Form 4 |
| Jun 3, 2026 | Smith Michael AlexanderChief Legal Officer | Sale | 2,159 | $220.80K | Form 4 |
| Jun 3, 2026 | Bonstein SaraChief Financial Officer | Sale | 2,404 | $245.86K | Form 4 |
| Jun 3, 2026 | Adsett RogerChief Operating Officer | Sale | 2,370 | $242.38K | Form 4 |
| May 22, 2026 | Smith Michael AlexanderChief Legal Officer | Sale | 6,149 | $666.98K | Form 4 |
| May 18, 2026 | Lewis WilliamChair and CEO | Sale | 7,975 | $853.09K | Form 4 |
| May 18, 2026 | Lewis WilliamChair and CEO | Sale | 11,836 | $1.26M | Form 4 |
| May 18, 2026 | Lewis WilliamChair and CEO | Sale | 5,753 | $605.91K | Form 4 |
| May 18, 2026 | Lewis WilliamChair and CEO | Option exercise | 4,440 | $76.19K | Form 4 |
| May 18, 2026 | Lewis WilliamChair and CEO | Option exercise | 6,259 | $190.65K | Form 4 |
| May 14, 2026 | Flammer Martina M.D.Chief Medical Officer | Sale | 10,479 | $1.23M | Form 4 |
| May 13, 2026 | Lewis WilliamChair and CEO | Sale | 13,283 | $1.54M | Form 4 |
| May 13, 2026 | LEE LEODirector | Award | 3,305 | — | Form 4 |
| May 13, 2026 | Flammer Martina M.D.Chief Medical Officer | Sale | 3,384 | $393.15K | Form 4 |
| May 13, 2026 | Flammer Martina M.D.Chief Medical Officer | Sale | 4,470 | $504.04K | Form 4 |
| May 13, 2026 | Desjardins ClarissaDirector | Award | 3,305 | — | Form 4 |
| May 13, 2026 | Smith Michael AlexanderChief Legal Officer | Sale | 4,109 | $477.38K | Form 4 |
| May 13, 2026 | Brennan David RDirector | Award | 3,305 | — | Form 4 |
| May 13, 2026 | SHAROKY MELVIN MDDirector | Award | 3,305 | — | Form 4 |
| May 13, 2026 | Bonstein SaraChief Financial Officer | Sale | 8,272 | $961.04K | Form 4 |
| May 13, 2026 | Adsett RogerChief Operating Officer | Sale | 5,837 | $678.14K | Form 4 |
| May 13, 2026 | SCHAFER CAROLDirector | Award | 3,305 | — | Form 4 |
| May 13, 2026 | ANDERSON ELIZABETH MDirector | Award | 3,305 | — | Form 4 |
| May 11, 2026 | Flammer Martina M.D.Chief Medical Officer | Sale | 830 | $83.98K | Form 4 |
| May 11, 2026 | Flammer Martina M.D.Chief Medical Officer | Sale | 12,119 | $1.22M | Form 4 |
| May 11, 2026 | Flammer Martina M.D.Chief Medical Officer | Option exercise | 12,949 | $221.04K | Form 4 |
| May 4, 2026 | Lewis WilliamChair and CEO | Sale | 381 | $53.19K | Form 4 |
| May 4, 2026 | Lewis WilliamChair and CEO | Sale | 1,247 | $173.45K | Form 4 |
| May 4, 2026 | Lewis WilliamChair and CEO | Sale | 2,721 | $375.12K | Form 4 |
| May 4, 2026 | Lewis WilliamChair and CEO | Sale | 5,318 | $728.62K | Form 4 |
| May 4, 2026 | Lewis WilliamChair and CEO | Sale | 599 | $80.97K | Form 4 |
| May 4, 2026 | Lewis WilliamChair and CEO | Sale | 433 | $58.10K | Form 4 |
| May 4, 2026 | Lewis WilliamChair and CEO | Option exercise | 4,440 | $76.19K | Form 4 |
| May 4, 2026 | Lewis WilliamChair and CEO | Option exercise | 6,259 | $190.65K | Form 4 |
| Apr 16, 2026 | Lewis WilliamChair and CEO | Sale | 825 | $120.28K | Form 4 |
| Apr 16, 2026 | Lewis WilliamChair and CEO | Sale | 2,255 | $326.21K | Form 4 |
| Apr 16, 2026 | Lewis WilliamChair and CEO | Sale | 5,373 | $772.69K | Form 4 |
| Apr 16, 2026 | Lewis WilliamChair and CEO | Sale | 2,246 | $321.16K | Form 4 |
| Apr 16, 2026 | Lewis WilliamChair and CEO | Option exercise | 4,440 | $76.19K | Form 4 |
| Apr 16, 2026 | Lewis WilliamChair and CEO | Option exercise | 6,259 | $190.65K | Form 4 |
| Apr 6, 2026 | Lewis WilliamChair and CEO | Sale | 1,434 | $235.19K | Form 4 |
| Apr 6, 2026 | Lewis WilliamChair and CEO | Sale | 8,478 | $1.38M | Form 4 |
| Apr 6, 2026 | Lewis WilliamChair and CEO | Sale | 787 | $127.28K | Form 4 |
| Apr 6, 2026 | Lewis WilliamChair and CEO | Option exercise | 4,440 | $76.19K | Form 4 |
| Apr 6, 2026 | Lewis WilliamChair and CEO | Option exercise | 6,259 | $190.65K | Form 4 |
| Apr 1, 2026 | Adsett RogerChief Operating Officer | Sale | 62,344 | $10.28M | Form 4 |
| Apr 1, 2026 | Adsett RogerChief Operating Officer | Sale | 19,001 | $3.12M | Form 4 |
| Apr 1, 2026 | Adsett RogerChief Operating Officer | Sale | 6,715 | $1.10M | Form 4 |
| Apr 1, 2026 | Adsett RogerChief Operating Officer | Option exercise | 88,060 | $1.28M | Form 4 |
| Mar 30, 2026 | Smith Michael AlexanderChief Legal Officer | Sale | 19,638 | $2.96M | Form 4 |
| Mar 30, 2026 | Smith Michael AlexanderChief Legal Officer | Option exercise | 13,989 | $390.15K | Form 4 |
| Mar 30, 2026 | Smith Michael AlexanderChief Legal Officer | Option exercise | 5,649 | $96.43K | Form 4 |
| Mar 19, 2026 | Lewis WilliamChair and CEO | Sale | 4,533 | $653.25K | Form 4 |
| Mar 19, 2026 | Lewis WilliamChair and CEO | Sale | 4,537 | $650.70K | Form 4 |
| Mar 19, 2026 | Lewis WilliamChair and CEO | Sale | 1,629 | $231.59K | Form 4 |
| Mar 19, 2026 | Lewis WilliamChair and CEO | Option exercise | 4,440 | $76.19K | Form 4 |
| Mar 19, 2026 | Lewis WilliamChair and CEO | Option exercise | 6,259 | $190.65K | Form 4 |
| Mar 5, 2026 | Lewis WilliamChair and CEO | Sale | 2,128 | $313.97K | Form 4 |
| Mar 5, 2026 | Lewis WilliamChair and CEO | Sale | 3,899 | $571.83K | Form 4 |
| Mar 5, 2026 | Lewis WilliamChair and CEO | Sale | 2,589 | $376.10K | Form 4 |
| Mar 5, 2026 | Lewis WilliamChair and CEO | Sale | 2,083 | $300.43K | Form 4 |
| Mar 5, 2026 | Lewis WilliamChair and CEO | Option exercise | 4,440 | $76.19K | Form 4 |
| Mar 5, 2026 | Lewis WilliamChair and CEO | Option exercise | 6,259 | $190.65K | Form 4 |
| Mar 3, 2026 | SHAROKY MELVIN MDDirector | Gift | 100 | — | Form 4 |
| Feb 25, 2026 | SHAROKY MELVIN MDDirector | Gift | 1,072 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4